CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain Successful catheter ablation of electrical storm after myocardial infarction Natural History of Spontaneous Coronary Artery Dissection With Spontaneous Angiographic Healing Cardiac monocytes and macrophages after myocardial infarction Predicting Major Adverse Events in Patients With Acute Myocardial Infarction An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With STEMI: A Cardiac Magnetic Resonance Study Cardiac Troponin Elevation in Patients Without a Specific Diagnosis Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I
|<<... 23 24 25 26 27 28 29 ...>>|

Original Research2018 Nov 7;39(42):3766-3776.

JOURNAL：Eur Heart J. Article Link

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Szummer K, Wallentin L, Lindhagen L et al. Keywords: Registry , Myocardial infarction , Time-trends , Outcomes

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top